Your email has been successfully added to our mailing list.

×
0.0407523510971788 0.0329153605015675 0.144200626959248 0.134796238244514 0.0658307210031349 0.0407523510971788 0.018025078369906 -0.0587774294670846
Stock impact report

NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) Combined with ...

NantKwest, Inc (NK)  More Company Research Source: Business Wire
Last nantkwest, inc earnings: 5/8 04:06 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nantkwest.com
PDF World’s first combination of tumor-targeted, off-the-shelf PD-L1-targeted Natural Killer cells with IL-15 fusion protein (N-803) to induce immune system activation of both the NK and T-cells demonstrated complete response in second-line metastatic pancreatic cancer, confirmed by PET/CT scan.Results consistent with durable complete responses recently reported in Triple Negative Breast Cancer (TNBC) when off-the-shelf CD-16 NK therapy was combined with ImmunityBio’s N-803.Over 130 doses of PD-L1.t-haNK cells safely administered in Phase 1 trial with no severe treatment-related adverse side effects.NantKwest plans to initiate registration trials in recurrent metastatic TNBC and pancreatic cancer patients that failed standard of care.N-803 received Breakthrough Designation from the FDA for BCG Unresponsive CIS non-muscle invasive bladder cancer.NantKwest plans to apply for Breakthrough Therapy Designation for advanced TNBC and pancreatic cancer.  CULVER CITY, Calif.--(BUSINESS WIRE)--N [Read more]
Impact snapshot Event time: NK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
NK alerts
from News Quantified
Opt-in for
NK alerts

from News Quantified
Opt-in for
NK alerts

from News Quantified